Brief: Idera Pharmaceuticals Reports Q1 Loss Per Share $0.40
May 2 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2019 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.40
* Q1 EARNINGS PER SHARE ESTIMATE $-0.46 -- REFINITIV IBES
DATA
* IDERA PHARMACEUTICALS - AS OF MARCH 31, 2019, OUR CASH,
CASH
EQUIVALENTS AND INVESTMENTS TOTALED $59.9 MILLION COMPARED TO
$71.4 MILLION AS OF DECEMBER 31, 2018
Source text for Eikon: ID:nGNX1BWXs5
Further company coverage: IDRA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary